Harbor Capital Advisors’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,899	Closed	-$110K	–	807
2023 Q4	$110K	Buy	1,899 +417	+28%	+$24.2K	0.02%	410
2023 Q3	$47.1K	Buy	1,482 +628	+74%	+$19.9K	0.01%	435
2023 Q2	$70.2K	Buy	+854	New	+$70.2K	0.01%	465